ImmunoCellular Therapeutics Ltd (IMUC.A)

IMUC.A on American Stock Exchange

0.64USD
21 Nov 2014
Price Change (% chg)

$-0.01 (-2.11%)
Prev Close
$0.65
Open
$0.65
Day's High
$0.65
Day's Low
$0.62
Volume
15,008
Avg. Vol
69,274
52-wk High
$4.00
52-wk Low
$0.54

IMUC.A

Chart for IMUC.A

About

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor... (more)

Overall

Beta: 1.18
Market Cap (Mil.): $40.77
Shares Outstanding (Mil.): 62.72
Dividend: --
Yield (%): --

Financials

  IMUC.A Industry Sector
P/E (TTM): -- 269.72 39.20
EPS (TTM): -0.12 -- --
ROI: -26.91 -1.77 17.16
ROE: -29.35 -3.18 18.09
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks